USP15 potentiates NF-kappa B activation by differentially stabilizing TAB2 and TAB3
USP15 potentiates NF-kappa B activation by differentially stabilizing TAB2 and TAB3
复制标题
USP15 通过差异稳定 TAB2 和 TAB3 来增强 NF-κB 激活
DOI:
10.1111/febs.15202
复制
发表时间:
2020
期刊:
影响因子:
5.4
通讯作者:
Huang Kun
中科院分区:
文献类型:
--
作者:
Zhou Qiaoqiao;Cheng Cheng;Wei Yujuan;Yang Jing;Zhou Wanzhu;Song Qiuyi;Ke Mengxiang;Yan Wanyao;Zheng Ling;Zhang Yu;Huang Kun
Tumor necrosis factor α (TNFα)‐ and interleukin 1β (IL‐1β)‐induced nuclear factor‐κB (NF‐κB) activation play key roles in inflammation, immunity, and cancer development. Here, we identified one of the deubiquitinating enzymes (DUBs), ubiquitin‐specific protease 15 (USP15), as a positive regulator in both TNFα‐ and IL‐1β‐induced NF‐κB activation. Overexpression of USP15 potentiated TNFα‐ or IL‐1β‐triggered NF‐κB activation and downstream gene transcription, whereas knockdown of USP15 had opposite effects. Mechanistically, upon TNFα stimulation, USP15 showed an enhanced interaction with transforming growth factor‐β activated kinase‐1 (TAK1)‐TAK1 binding protein (TAB) complex to inhibit the proteolysis of TAB2/3 by different pathways. Apart from deubiquitination dependently inducing cleavage of lysine 48‐linked TAB2 ubiquitination, USP15 also DUB independently inhibited lysosome‐associated TAB2 degradation, thus enhanced TAB2 stabilization. For TAB3, USP15 inhibited NBR1‐mediated selective autophagic TAB3 degradation independent of its deubiquitinating activity. Together, our results reveal a novel USP15‐mediated mechanism through which efficient NF‐κB activation is achieved by differentially maintaining the TAB2/3 stability.